China Sunsine Chemical Holdings (QES) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
27 Oct, 2026Executive summary
1H24 revenue rose 1% YoY to RMB1,749.1m as 6% higher sales volume offset a 4% decline in ASP; gross profit rose 5% to RMB433.6m.
PBT increased 14% to RMB268.1m, while net profit fell 3% to RMB188.8m as income tax expense rose 91% to RMB79.3m.
Sales volume reached a first-half record of 105,464 tonnes; international volume grew 20% while domestic volume declined 2%.
Financial highlights
Gross margin increased to 24.8% from 23.8%; PBT growth reflected higher gross profit and lower administrative expenses.
Selling and distribution expenses rose 4% to RMB52.6m on higher freight and port charges; administrative expenses fell 10% to RMB95.2m.
Other income was RMB33.5m, mainly interest income; net other gains of RMB18.7m mainly reflected USD appreciation against RMB.
Basic and diluted EPS was RMB19.71 cents versus RMB20.17 cents; NAV per share was RMB416.22 cents at 30 June 2024.
Revenue fell 1% versus 2H23 as lower volume offset higher ASP; gross profit rose 12% versus 2H23.
Outlook and guidance
Management expects profitability to remain sound over the next 12 months, pursuing sales-production equilibrium, customer focus and higher sales volume.
Phase II of the 30,000-tonne-per-year insoluble sulphur project is undergoing machinery installation, with completion expected by end-2024.
Phase I of the continuous high-quality MBT project has 20,000-tonne-per-year capacity and remains in trial run; trial completion is expected in 3Q24 and commercial production in 4Q24.
Latest events from China Sunsine Chemical Holdings
- Record volume could not offset lower ASP, cutting FY2023 net profit 42%.QES
H2 2023 - A 22% ASP decline outweighed 10% volume growth, cutting net profit 54%.QES
H1 2023 - Net profit rose 29% as record sales volume partly offset lower selling prices.QES
H1 2025 - Record sales volume and higher margins lifted revenue, while FX losses and working capital weighed on cash flow.QES
H1 2026 - Record volume growth could not offset lower ASP, cutting FY2025 revenue 7% and profit 4%.QES
H2 2025 - Record FY2024 volume lifted net profit 14% despite ASP pressure and intense competition.QES
H2 2024